Financial Management Professionals, Inc. Charles River Laboratories International, Inc. Transaction History

Financial Management Professionals, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 13, 2023	BUY	$191.89 - $259.92 $3,070 - $4,158	16 New	16 $3,000
Q1 2022 Apr 27, 2022	SELL	$255.51 - $362.11 $51,357 - $72,784	-201 Closed	0 $0
Q4 2021 Jan 28, 2022	SELL	$351.38 - $448.68 $1,054 - $1,346	-3 Reduced 1.47%	201 $76,000
Q3 2021 Nov 02, 2021	BUY	$372.64 - $458.3 $4,471 - $5,499	12 Added 6.25%	204 $84,000
Q2 2021 Aug 05, 2021	SELL	$294.17 - $371.65 $18,238 - $23,042	-62 Reduced 24.41%	192 $71,000
Q1 2021 Apr 26, 2021	BUY	$249.67 - $299.48 $1,747 - $2,096	7 Added 2.83%	254 $74,000
Q4 2020 Feb 03, 2021	BUY	$222.0 - $252.62 $1,776 - $2,020	8 Added 3.35%	247 $62,000
Q2 2020 Jul 21, 2020	BUY	$118.84 - $189.72 $28,402 - $45,343	239 New	239 $42,000

721

52M

233K

236K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.49B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Financial Management Professionals, Inc., based on Form 13F filings with the SEC.

Stay updated on Financial Management Professionals, Inc. with notifications on news.